Direct 35 Keytruda Keytruda (pembrolizumab) 3541.69 Merck Sharp Medicines/Oncology/Colorectal Cancer 0

Keytruda (pembrolizumab)

We support you to access approved medicine that is not approved or available in your country of residence. Make an enquiry below to learn more.

Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer.

Note: Keytruda (pembrolizumab) is currently only available in 100mg form (100mg/4ml). There used to be a 50mg presentation but this has been discontinued as of March 15th, 2019.


Disease Indications

Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer


Merck Sharp



Medicine approved by

  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • Therapeutic Goods Administration (TGA)
  • Medsafe (NZ)

Patients helped

  • Over 1.2 million patients reached
  • Over 11,000 patients helped
  • 13,000 medicines supplied
  • 100% success delivering to people in 85 countries

Safe and Secure

We are registered with the Dutch Ministry of Health in The Hague, as an intermediary, registration number: 6730 BEM and as a wholesale distributor, registration number: 16258 G.



1 vial of powder for infusion

Price estimate:


The price, packaging size and strength may vary due to product availability. Make an enquiry for more information.

Make an enquiry

Our Patient Support Team will personally assist you along the way

Dr. Akshi Sudan

Patient Support Manager

Maria Chironi

Patient Support

Our patients share their stories

Read more
This content has been reviewed by a Medical Doctor.

Patient reviews

Lika's review
Lika Dzneladze


“I want to recommend everyone to work with this organization. They are reliable, honest, punctual and do everything to meet your needs…”

Eran's review
Eran Margalith


“Dr. Aysen Simsek and her team offered assistance during a very difficult time. I truly appreciate their quick, efficient and professional attitude, as well as their patience and superb customer service…”

Ana's review
Ana Coric

Patient's relative

“I highly recommend TheSocialMedwork. They welcomed me with open arms when I went to their office in Amsterdam. I was in a very difficult situation with a tight schedule, and their amazing team members…”

We are highly rated by our patients

About us

We are TheSocialMedwork, a registered medical intermediary that helps you access elsewhere approved medicines, no matter where you live. To date, we have assisted patients in over 80 countries to access thousands of life-improving medicines.

Learn more

About us

Pill icon
Learn how to access medicines
Read more
FAQ icon
Frequently Asked Questions from our patients
Read more


Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.